最新ニュース OSR Holdings (NASDAQ:OSRH) 株価情報

OSR Holdings

OSR Holdings Inc is a healthcare company, dedicated to healthcare outcomes and improving the quality of life for people and their families. It builds and develops a robust portfolio of and potentially transformative therapies and healthcare solutions.

OSR Holdings Inc

Piper Sandler analyst Clarke Jeffries maintains BILL Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BILL#NYSE">BILL</a>) with a Overweight and lowers the price target from $85 to $70.

News

Price Target

Analyst Ratings

BILL

Piper Sandler Maintains Overweight on BILL Holdings, Lowers Price Target to $70

The <a href="https://www.benzinga.com/markets/cryptocurrency/24/09/40961791/the-biggest-crypto-crime-cases-in-2024-heists-frauds-and-multi-million-dollar-scams-shake-">New York State Department of Financial Services</a> (DFS) has fined Block, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XYZ#NYSE">XYZ</a>) $40 million for violations tied to its anti-money laundering and virtual currency compliance protocols on the Cash App platform.
The enforcement <a href="https://www.dfs.ny.gov/reports_and_publications/press_releases/pr202504101">action</a> follows a state-led investigation revealing significant regulatory gaps in customer identification and transaction monitoring, increasing the risk of illicit financial activity.
According to DFS Superintendent Adrienne A. Harris, the fine addresses years of insufficient oversight at Cash App, particularly in handling high-risk Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) transactions and managing transaction alerts during the app's rapid expansion between 2019 and 2020.
"Compliance functions must keep pace with company growth or expansion," said Harris. "The rapid growth of Block's Cash App absent a robust compliance function created risk and vulnerabilities that violated the rules financial services companies operating in New York must adhere to."
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/25/04/44739006/crypto-leverage-trading-in-the-us-may-become-more-accessible-heres-why">Crypto Leverage Trading In The US May Become More Accessible: Here&#8217;s Why</a>
The state's probe found that Block failed to perform adequate customer due diligence and lacked effective systems to identify and prevent money laundering. 
One critical concern was the processing of anonymous, high-risk Bitcoin transactions without sufficient scrutiny, along with a significant backlog of unreviewed alerts that went unaddressed for a prolonged period.
Under the settlement, Block must appoint an independent monitor to oversee the development of an improved compliance program. 
DFS said the company has cooperated throughout the investigation and is already investing in corrective measures.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/04/44738201/bitcoin-could-surge-to-250000-says-cardano-co-founder-charles-hoskinson">Bitcoin Could Surge To $250,000, Says Cardano Co-Founder Charles Hoskinson</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

Block Fined $40 Million By New York Regulator Over Cash App Compliance Failures

Wells Fargo analyst Elyse Greenspan maintains Axis Capital Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AXS#NYSE">AXS</a>) with a Equal-Weight and raises the price target from $97 to $100.

Wells Fargo Maintains Equal-Weight on Axis Capital Holdings, Raises Price Target to $100

Wells Fargo analyst Elyse Greenspan maintains American International Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AIG#NYSE">AIG</a>) with a Equal-Weight and lowers the price target from $82 to $81.

Wells Fargo Maintains Equal-Weight on American International Gr, Lowers Price Target to $81

Goldman Sachs analyst Jordan Alliger maintains Werner Enterprises (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WERN#NASDAQ">WERN</a>) with a Sell and lowers the price target from $36 to $28.

WERN

Goldman Sachs Maintains Sell on Werner Enterprises, Lowers Price Target to $28

WIIM

APLE

Shares of REIT stocks are trading lower amid an overall market reversal. The sector may also be down amid a rise in the 30-year Treasury yield.

Wells Fargo analyst Michael Turrin maintains Atlassian (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TEAM#NASDAQ">TEAM</a>) with a Overweight and lowers the price target from $375 to $330.

TEAM

Wells Fargo Maintains Overweight on Atlassian, Lowers Price Target to $330

Goldman Sachs analyst Mark Delaney maintains Vertiv Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VRT#NYSE">VRT</a>) with a Buy and lowers the price target from $135 to $85.

Goldman Sachs Maintains Buy on Vertiv Holdings, Lowers Price Target to $85

UBS analyst Michael Lasser maintains Walmart (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WMT#NYSE">WMT</a>) with a Buy and lowers the price target from $112 to $110.

UBS Maintains Buy on Walmart, Lowers Price Target to $110

Goldman Sachs analyst Mark Delaney maintains TE Connectivity (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TEL#NYSE">TEL</a>) with a Buy and lowers the price target from $190 to $170.

Goldman Sachs Maintains Buy on TE Connectivity, Lowers Price Target to $170

Goldman Sachs analyst Mark Delaney maintains Symbotic (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SYM#NASDAQ">SYM</a>) with a Neutral and lowers the price target from $25 to $18.

Goldman Sachs Maintains Neutral on Symbotic, Lowers Price Target to $18

Goldman Sachs analyst Kash Rangan maintains ServiceNow (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOW#NYSE">NOW</a>) with a Buy and lowers the price target from $1200 to $1050.

Goldman Sachs Maintains Buy on ServiceNow, Lowers Price Target to $1050

UBS analyst Nicholas Holowko upgrades Comerica (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMA#NYSE">CMA</a>) from Sell to Neutral and announces $59 price target.

Upgrades

UBS Upgrades Comerica to Neutral, Announces $59 Price Target

UBS analyst Joshua Chan maintains ManpowerGroup (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MAN#NYSE">MAN</a>) with a Neutral and lowers the price target from $63 to $57.

UBS Maintains Neutral on ManpowerGroup, Lowers Price Target to $57

Goldman Sachs analyst Jordan Alliger maintains Schneider National (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNDR#NYSE">SNDR</a>) with a Neutral and lowers the price target from $28 to $23.

SNDR

Goldman Sachs Maintains Neutral on Schneider National, Lowers Price Target to $23

UBS analyst Kunal Madhukar maintains Cars.com (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CARS#NYSE">CARS</a>) with a Neutral and lowers the price target from $15 to $13.

CARS

UBS Maintains Neutral on Cars.com, Lowers Price Target to $13

Goldman Sachs analyst Jordan Alliger maintains RXO (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RXO#NYSE">RXO</a>) with a Neutral and lowers the price target from $24 to $21.

Goldman Sachs Maintains Neutral on RXO, Lowers Price Target to $21

Goldman Sachs analyst Mark Delaney maintains Rivian Automotive (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RIVN#NASDAQ">RIVN</a>) with a Neutral and lowers the price target from $14 to $12.

RIVN

Goldman Sachs Maintains Neutral on Rivian Automotive, Lowers Price Target to $12

UBS analyst Kunal Madhukar maintains CarGurus (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CARG#NASDAQ">CARG</a>) with a Neutral and lowers the price target from $36 to $29.

CARG

UBS Maintains Neutral on CarGurus, Lowers Price Target to $29

GRMN

Shares of homebuilders and household durables stocks are trading lower amid an overall market reversal following Wednesday's surge.

Press Releases

OSR Holdings Appoints Dr. Constance Höfer as Chief Scientific Officer

Vaximm AG, an OSR Company, Announces Results from Phase 2a Trial of VXM01 and Avelumab Combination Therapy in Glioblastoma

Driving the Future of Healthcare HIT, OSRH, THTX, LPTX, CSDX, Innovations in Health Insurance, Virtual Care, Oncology, and Chronic Disease Treatment

OSR Holdings, Inc. (NASDAQ: OSRH) Enters Into $80 Million Common Stock Purchase Agreement With White Lion GBM Innovation Fund, With An Eye Towards Leveraging Innovate GBM's Non-Profit Ecosystem to Accelerate Glioblastoma Therapies

Comments

OSR Holdings

ニュース

最新ニュース OSR Holdings (NASDAQ:OSRH) 株価情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル